Form D Explorer

Inspect source fieldsReport a record issue

Form D — King Therapeutics LLC

0002088073-25-000001 · filed Oct 15, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other filings

Offering

Industry
Other
Exemptions
Rule 506(b)
Reported offering amount
$500,000
Reported amount sold
$310,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
King Therapeutics LLC
CIK
2088073
Entity
Limited Liability Company
Jurisdiction
DELAWARE
Year incorporated
2024
Address
12006 S. 44TH ST.
PHOENIX, Arizona 85044
Phone
602-516-2199

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗